VETOP Stock Overview

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. More details

VETOP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	5/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 39.8% below our estimate of its fair value

Earnings are forecast to grow 4.8% per year

Earnings grew by 15.8% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Vetoquinol SA Competitors

Hikma Pharmaceuticals

LSE:HIK

UK£5.1b

Animalcare Group

AIM:ANCR

UK£166.9m

ECO Animal Health Group

AIM:EAH

UK£39.6m

Haleon

LSE:HLN

UK£34.8b

Price History & Performance

Summary of share price highs, lows and changes for Vetoquinol
Historical stock prices
Current Share Price	€100.60
52 Week High	€100.60
52 Week Low	€100.60
Beta	0.91
1 Month Change	0%
3 Month Change	-0.79%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	86.99%
Change since IPO	285.81%

Recent updates

Shareholder Returns

	VETOP	GB Pharmaceuticals	GB Market
7D	0%	0.7%	0.3%
1Y	n/a	8.2%	10.4%

Return vs Industry: Insufficient data to determine how VETOP performed against the UK Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how VETOP performed against the UK Market.

Price Volatility

Is VETOP's price volatile compared to industry and market?
VETOP volatility
VETOP Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.9%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.4%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: VETOP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine VETOP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1933	2,497	Matthieu Frechin	www.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France.

Vetoquinol SA Fundamentals Summary

How do Vetoquinol's earnings and revenue compare to its market cap?
VETOP fundamental statistics
Market cap	€1.16b
Earnings (TTM)	€55.60m
Revenue (TTM)	€529.30m

20.9x

P/E Ratio

2.2x

P/S Ratio

Is VETOP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VETOP income statement (TTM)
Revenue	€529.30m
Cost of Revenue	€0
Gross Profit	€529.30m
Other Expenses	€473.70m
Earnings	€55.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 12, 2024

Earnings per share (EPS)	4.70
Gross Margin	100.00%
Net Profit Margin	10.50%
Debt/Equity Ratio	3.1%

How did VETOP perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

16%

Payout Ratio

Does VETOP pay a reliable dividends?

See VETOP dividend history and benchmarks

When do you need to buy VETOP by to receive an upcoming dividend?
Vetoquinol dividend dates
Ex Dividend Date	Jun 04 2024
Dividend Pay Date	Jun 06 2024
Days until Ex dividend	258 days
Days until Dividend pay date	256 days

Does VETOP pay a reliable dividends?

See VETOP dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/11 21:34
End of Day Share Price	2024/02/12 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vetoquinol SA is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Carole Rozen	CA Cheuvreux
Arnaud Cadart	CIC Market Solutions (ESN)
Alexandre Letz	Gilbert Dupont

Vetoquinol BATS-CHIXE:VETOP Stock Report